Skip to main content

Advertisement

Table 1 (abstract P199). Demographics and clinical characteristics by immune status

From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)

  Non-immune (n=414) Immune (n=178) P-value
Age (y)
 7-10 years 30 (7%) 20 (11%) 0.00
 11-15 years 129 (31%) 39 (22%)
 16-20 years 188 (46%) 73 (41%)
 > 20 years 67 (16%) 46 (26%)
Biologic*
 Anti TNF 310 (75%) 139 (78%) 0.95
 Anti IL-6 42 (10%) 12 (7%) 0.44
 Anti IL-1 16 (4%) 3 (2%) 0.29
 Anti T-cell 35 (8%) 11 (6%) 0.60
 Anti B-cell 14 (3%) 14 (8%) 0.00
 Others 9 (2%) 1 (1%) 0.20
  1. Continuous variables reported as mean (standard deviation). Categorical variables reported as frequency (percentage). P-values in bold are statistically significant
  2. * This reflects the number of patients with history of medication use (% is reported out of total patients)